XJPX
3141
Market cap4.04bUSD
Nov 26, Last price
3,160.00JPY
Name
Welcia Holdings Co Ltd
Chart & Performance
P/E
43.86
P/S
0.51
EPS
72.05
Div Yield, %
1.11%
Shrs. gr., 5y
-0.16%
Rev. gr., 5y
8.16%
Revenues
1.29t
+5.56%
Net income
14.96b
-43.45%
CFO
47.85b
+2.83%
Dividend
Aug 28, 202518 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Welcia Holdings Co., Ltd. oversees a substantial network of drugstores across Japan, many of which are equipped with integrated dispensing pharmacies. These retail outlets provide a diverse array of merchandise, encompassing over-the-counter medicines, health and nursing care products, infant essentials, and health foods. Their inventory further extends to include cosmetics, household items, and groceries, alongside prescription services. Beyond its retail operations, the company offers a range of support services, such as counseling, late-night store access, and comprehensive long-term care programs. They also facilitate in-home assistance, including bathing and nursing care support visits. Furthermore, Welcia Holdings engages in the rental and sale of welfare equipment and provides residential services specifically designed for senior citizens. As of February 28, 2022, Welcia Holdings operated 2,468 locations. Established in 2008, the company is based in Tokyo, Japan, and functions as a subsidiary of Aeon Co., Ltd.
IPO date
Sep 01, 2008
Employees
14,865
Domiciled in
JP
Incorporated in
JP
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑02 | 2024‑02 | 2023‑02 | 2022‑02 | 2021‑02 | 2020‑02 | 2019‑02 | 2018‑02 | 2017‑02 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||